194 related articles for article (PubMed ID: 9412419)
1. [Amoxycillin/potassium clavulanate (augmentin)--current importance in the treatment of infection].
Fomina IP
Antibiot Khimioter; 1997; 42(9):36-43. PubMed ID: 9412419
[No Abstract] [Full Text] [Related]
2. [Amoxycillin/clavulanic acid--beginning of new era in antibiotic therapy of bacterial infections].
Iarkin MV
Antibiot Khimioter; 1998; 43(5):47-8. PubMed ID: 9644525
[No Abstract] [Full Text] [Related]
3. [Augmentin and respiratory tract infections in the adult: current aspects].
Chidiac C
Presse Med; 2000 Sep; 29(26 Suppl):3-4. PubMed ID: 11045110
[No Abstract] [Full Text] [Related]
4. Efficacy and safety of pharmacokinetically enhanced amoxicillin-clavulanate at 2,000/125 milligrams twice daily for 5 days versus amoxicillin-clavulanate at 875/125 milligrams twice daily for 7 days in the treatment of acute exacerbations of chronic bronchitis.
Sethi S; Breton J; Wynne B
Antimicrob Agents Chemother; 2005 Jan; 49(1):153-60. PubMed ID: 15616290
[TBL] [Abstract][Full Text] [Related]
5. A world-wide summary of clinical experience with augmentin.
Croydon P
J Chemother; 1989 Jul; 1(4 Suppl):644-5. PubMed ID: 16312572
[No Abstract] [Full Text] [Related]
6. Erythema multiforme secondary to amoxicillin/clavulanic acid exposure.
Benjamin S; Mueller BA
Ann Pharmacother; 1999 Jan; 33(1):109-10. PubMed ID: 9972393
[No Abstract] [Full Text] [Related]
7. [Augmentin--current and prospective therapeutic indications].
Mihălţan F
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1988; 37(3):203-10. PubMed ID: 2855664
[No Abstract] [Full Text] [Related]
8. Amoxicillin-clavulante as the gold standard empirical therapy of acute bacteria rhinosinusitis.
Brook I
Expert Rev Anti Infect Ther; 2012 Dec; 10(12):1367-9. PubMed ID: 23253313
[No Abstract] [Full Text] [Related]
9. Augmentin (amoxicillin/clavulanate) in the treatment of community-acquired respiratory tract infection: a review of the continuing development of an innovative antimicrobial agent.
White AR; Kaye C; Poupard J; Pypstra R; Woodnutt G; Wynne B
J Antimicrob Chemother; 2004 Jan; 53 Suppl 1():i3-20. PubMed ID: 14726431
[TBL] [Abstract][Full Text] [Related]
10. [Antibiotics in therapy of bacterially infected diabetic foot. Results in 191 patients].
Schiewe U; Gerards HH
MMW Fortschr Med; 1999 Dec; 141(49-50):42. PubMed ID: 10726146
[No Abstract] [Full Text] [Related]
11. A randomized, observer-blind trial of amoxycillin/clavulanate versus cefaclor in the treatment of children with acute otitis media. Augmentin 415 Study Group.
Subba Rao SD; Macias MP; Dillman CA; Ramos BD; Kierszenbaum JS; Soliman AE
J Chemother; 1998 Dec; 10(6):460-8. PubMed ID: 9876054
[TBL] [Abstract][Full Text] [Related]
12. [The clinical efficacy of augmentin (amoxicillin/clavulanate) in treating inflammatory diseases of the urogenital organs].
Tkachuk VN
Antibiot Khimioter; 2000; 45(3):9-11. PubMed ID: 10768059
[TBL] [Abstract][Full Text] [Related]
13. Double-blind, randomized study of the efficacy and safety of oral pharmacokinetically enhanced amoxicillin-clavulanate (2,000/125 milligrams) versus those of amoxicillin-clavulanate (875/125 milligrams), both given twice daily for 7 days, in treatment of bacterial community-acquired pneumonia in adults.
File TM; Lode H; Kurz H; Kozak R; Xie H; Berkowitz E;
Antimicrob Agents Chemother; 2004 Sep; 48(9):3323-31. PubMed ID: 15328092
[TBL] [Abstract][Full Text] [Related]
14. The clinical pharmacology of amoxicillin and clavulanic acid.
Reed MD
Pediatr Infect Dis J; 1998 Oct; 17(10):957-62. PubMed ID: 9802653
[No Abstract] [Full Text] [Related]
15. [Augmentin].
Foster M
Antibiot Khimioter; 1992 Sep; 37(9):3-9. PubMed ID: 1444667
[No Abstract] [Full Text] [Related]
16. [Why is the augmentin dose changing?].
Chahwakilian P
Presse Med; 2000 Sep; 29(26 Suppl):5-7. PubMed ID: 11045111
[No Abstract] [Full Text] [Related]
17. Effect of amoxicillin-clavulanate in clinically diagnosed acute rhinosinusitis: a placebo-controlled, double-blind, randomized trial in general practice.
Bucher HC; Tschudi P; Young J; Périat P; Welge-Lüussen A; Züst H; Schindler C;
Arch Intern Med; 2003 Aug 11-25; 163(15):1793-8. PubMed ID: 12912714
[TBL] [Abstract][Full Text] [Related]
18. [Amoxycillin-clavulanic acid in patients with spontaneous bacterial peritonitis].
Andrade RJ; Lucena MI; García-Cortés M; Alcántara R; Fernández E
Gastroenterol Hepatol; 2001; 24(7):367-8. PubMed ID: 11481077
[No Abstract] [Full Text] [Related]
19. Augmentin (Amoxycillin and clavulanic acid) in the treatment of urinary tract infections and skin and soft tissue infections.
Tan TH; Tay L; Yeo M; Feng PH
Singapore Med J; 1983 Oct; 24(5):299-302. PubMed ID: 6669995
[No Abstract] [Full Text] [Related]
20. Amoxycillin clavulanate: an assessment after 15 years of clinical application.
Ball P; Geddes A; Rolinson G
J Chemother; 1997 Jun; 9(3):167-98. PubMed ID: 9210001
[No Abstract] [Full Text] [Related]
[Next] [New Search]
